Arkolith/Insider Trading/RYZB/Form 4

Katabi Maha

DirectorRayzeBio, Inc. (RYZB) · full profile →Form 4 · filed Sep 21, 2023
Net Buying
Open-Market Buys
$8.5M
Open-Market Sells
$0
Net Open-Market Flow
$8.5M
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 19, 2023Conversion(C)974K——974K
Sep 19, 2023Buy(P)236K$18.00$4.2M1.2M
Sep 19, 2023Buy(P)236K$18.00$4.2M1.2M
Sep 19, 2023Conversion(C)974K——974K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 19, 2023Conversion(C)974K——0
Sep 19, 2023Conversion(C)974K——0

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-050305) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML